Gene · 8991
SELENBP1: selenium binding protein 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SELENBP1: selenium binding protein 1. Genes, record 8991. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8991
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q13228 | Methanethiol oxidase | 472 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents48
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 62883 | Q13228 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8519 | Q13228 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8519 | Q13228 | Espacenet |
| JP 2023049296 A | 2023-04-10 | 37 | Q13228 | Espacenet |
| JP 2022141755 A | 2022-09-29 | 17 | Q13228 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 77179 | Q13228 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 180150 | Q13228 | Espacenet |
| JP 2021018154 A | 2021-02-15 | 893 | Q13228 | Espacenet |
| US 10849841 B2 | 2020-12-01 | 313 | Q13228 | Espacenet |
| JP 2020062004 A | 2020-04-23 | 1361 | Q13228 | Espacenet |
1 to 10 of 48
See all 48 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,559
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SELENBP1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P20GM103449 | Vermont Biomedical Research Network-Vermont INBRE | 5 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 5 | 2025 |
| R01AI155447 | Systemic coordination of pro-inflammatory immune reactions through dendritic cell-restricted sIL6R biogenesis | 5 | 2025 |
| T32AI007245 | Molecular Basis of Viral Infectivity | 5 | 2025 |
| ZIAHL006001 | Framingham Project/Levy | 5 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 4 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 4 | 2025 |
| P30CA072720 | Cancer Center Support Grant | 4 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 4 | 2025 |
1 to 10 of 1,559Source NIH's project files
See all 1,559 nih grantsPapers2,273
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Transcriptomic and Biochemical Profiling Reveals the Regulatory Mechanism of Light Intensity-Induced Anthocyanin Biosynthesis in a Purple-Leaf Tea Cultivar. | Plants (Basel) | 2026 | 42796836 | PubTator, text mining | PubMed |
| Somatic Mutation Profile in Normal Tissue Adjacent to Tumor in Colorectal Carcinoma Patients: Functional Effect on Gene Expression and Potential Implications for Precision Medicine. | Cancers (Basel) | 2026 | 42795000 | PubTator, text mining | PubMed |
| Evolutionary Conservation of the Copper-Dependent Thiol Oxidase Activity of Selenium-Binding Proteins. | Antioxidants (Basel) | 2026 | 42792187 | PubTator, text mining | PubMed |
| Molecular mechanisms of protein disulfide isomerase antagonism by punicalagin. | Biochem Biophys Res Commun | 2026 | 42623842 | PubTator, text mining | PubMed |
| Selenium-Binding Protein 1 Deficiency Inhibits the Antitumor Immunity of Dendritic Cells. | Antioxid Redox Signal | 2026 | 42557222 | PubTator, text mining | PubMed |
| Structural insights into xyloglucan recognition by an ABC transporter from a Gram-positive, thermophilic bacterium. | FEBS J | 2026 | 42545829 | PubTator, text mining | PubMed |
| Bioinformatics reveals the prognostic potential of manganese metabolism-related genes in lung adenocarcinoma. | Funct Integr Genomics | 2026 | 42472729 | PubTator, text mining | PubMed |
| Structural characterization of an α-glucosaccharide-binding protein from Paenibacillus sp. str. FPU-7. | J Struct Biol X | 2026 | 42375807 | PubTator, text mining | PubMed |
| Validation of De Novo Designs of Solid-Binding Peptides. | ACS Cent Sci | 2026 | 42369908 | PubTator, text mining | PubMed |
| USP48 functions as a suppressor of colorectal cancer via SELENBP1 stabilization. | Transl Oncol | 2026 | 42364493 | PubTator, text mining | PubMed |
1 to 10 of 2,273
See all 2,273 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8991
GET https://conductscience.org/api/genes/v1/8991/patents?page=2